Superoxide-dependent cerebrovascular effects of homocysteine

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 274, Issue 6 43-6, 1998, Pages

  Zhang, Fangyi ^a   Slungaard, Arne ^b   Gregory, M ^a   Vercellotti, ^b   Iadecola, Costantino ^a  

^a Laboratory of Cerebrovàscular Biology and Stroke   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Cerebral circulation; Nitric oxide; Rat; Vasodilation

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; BRAIN OXYGEN CONSUMPTION; CEREBROVASCULAR DISEASE; HYPERHOMOCYSTEINEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION; VASOMOTOR REFLEX;

EID: 0031778291     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1998.274.6.r1704     Document Type: Article

References (35)

1. Blennow, G., J. Folbergrova, B. Nilsson, and B. K. Siesjo. Cerebral metabolic and circulatory changes in the rat during sustained seizures induced by DL-homocysteine. Brain Res. 179: 129-146, 1979.
2. Boers, G. H., A. G. Smals, F. J. Trijbels, B. Fowler, J. A. Bakkeren, H. C. Schoonderwaldt, W. J. Kleijer, and P. W. Kloppenborg. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N. Engl. J. Med. 313: 709-715, 1985.
3. Brattstrom, L., and A. Lindgren. Hyperhomocysteinemia as a risk factor for stroke. Neural. Res. 14: 81-84, 1992.
4. Brattstrom, L., A. Lindgren, B. Israelsson, M. R. Malinow, B. Norrving, B. Upson, and A. Hamfelt. Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors. Eur. J. Clin. Invest. 22: 214-221, 1992.
5. Broch, O. J., and P. M. Ueland. Regional and subcellular distribution of S-adenosylhomocysteine hydrolase in the adult rat brain. J. Neurochem. 35: 484-488, 1980.
6. Cavallini, D. M. C. De, S. Dupre, and G. Rotilio. The copper catalyzed oxidation of cysteine to cystine. Arch. Biochem. Biophys. 130: 354-361, 1969.
7. Coull, B. M., M. R. Malinow, N. Beamer, G. Sexton, F. Nordt, and P. de Garmo. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke 21: 572-576, 1990.
8. Crow, J. P., and J. S. Beckman. Reactions between nitric oxide, superoxide and peroxynitrite: footprints of perxynitrite in vivo. In: Nitric Oxide. Biochemistry, Molecular Biology and Therapeutic Implications, edited by L. Ignarro and F. Murad. San Diego, CA: Academic, 1995, p. 17-43.
9. Dirnagl, U., K. Niwa, U. Lindauer, and A. Villringer. Coupling of cerebral blood flow to neuronal activation: role of adenosine and nitric oxide. Am. J. Physiol. 267 (Heart Circ. Physiol. 36): H296-H301, 1994.
10. Faraci, F. M., K. R. Breese, and D. D. Heistad. Cerebral vasodilation during hypercapnia. Role of glibenclamide-sensitive potassium channels and nitric oxide. Stroke 25: 1679-1683, 1994.
11. Giles, W. H., S. J. Kittner, R. F. Anda, J. B. Croft, and M. L. Casper. Serum folate and risk for ischemic stroke. First National Health and Nutrition Examination Survey Epidemiologie Follow-Up Study. Stroke 26: 1166-1170, 1995.
12. Harker, L. A., R. Ross, S. J. Slichter, and C. R. Scott. Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J. Clin. Invest. 58: 731-741, 1976.
13. Harker, L. A., S. J. Slichter, C. R. Scott, and R. Ross. Homocystinemia. Vascular injury and arterial thrombosis. N. Engl. J. Med. 291: 537-543, 1974.
14. Iadecola, C. Does nitric oxide mediate the increases in cerebral blood flow elicited by hypercapnia? Proc. Natl. Acad. Sci. USA 89: 3913-3916, 1992.
15. Iadecola, C. Bright and dark sides of nitric oxide in ischemic brain damage. Trends Neurosci. 20:132-138,1997.
16. ladecola, C., and F. Zhang. Permissive and obligatory roles of NO in cerebrovascular responses to hypercapnia and acetylcholine. Am. J. Physiol. 271 (Regulatory Integrative Comp. Physiol. 40): R990-R1001, 1996.
17. Iadecola, C., F. Zhang, and X. Xu. SIN-1 reverses attenuation of hypercapnic cerebrovasodilation by nitric oxide synthase inhibitors. Am. J. Physiol. 267 (Regulatory Integrative Comp. Physiol. 36): R228-R235, 1994.
18. Kontos, H. A., E. P. Wei, W. D. Dietrich, R. M. Navari, J. T. Povlishock, N. R. Ghatak, E. F. Ellis, and J. J. Patterson. Mechanism of cerebral arteriolar abnormalities after acute hypertension. Am. J. Physiol. 240 (Heart Circ. Physiol. 9): H511-H527, 1981.
19. Lentz, S. R., C. G. Sobey, D. J. Piegors, M. Y. Bhopatkar, F. M. Faraci, M. R. Malinow, and D. D. Heistad. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J. Clin. Invest. 98: 24-29, 1996.
20. Li, J., and C. Iadecola. Nitric oxide and adenosine mediate vasodilation during functional activation in cerebellar cortex. Neuropharmacotogy 33: 1453-1461, 1994.
21. Misra, H. P. Generation of superoxide free radical during the autoxidation of thiols. J. Biol. Chem. 249: 2151-2155, 1974.
22. Mudd, S. H., F. Skovby, H. L. Levy, K. D. Pettigrew, B. Wilcken, R. E. Pyeritz, G. Andria, G. H. Boers, I. L. Bromberg, R. Cerone, B. Fowler, H. Gröbe, H. Schmidt, and L. Schweitzer. The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am. J. Hum. Genet. 37: 1-31, 1985.
23. Munday, R. Tbxicity of thiols and disulphides: involvement of free-radical species. Free Radic. Biol. Med. 7: 659-673, 1989.
24. Rees, M. M., and G. M. Rodgers. Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis. Thromb. Res. 71: 337-359, 1993.
25. Rosenblum, W. I., G. H. Nelson, and J. T. Povlishock. Laser-induced endothelial damage inhibits endothelium-dependent relaxation in the cerebral microcirculation of the mouse. Circ. Res. 60: 169-176, 1987.
26. Sciotti, V. M., and D. G. Van Wylen. Attenuation of ischemiainduced extracellular adenosine accumulation by homocysteine. J. Cereb. Blood Flow Metab. 13: 208-213, 1993.
27. Stamler, J. S., J. A. Osborne, O. Jaraki, L. E. Rabbani, M. Mullins, D. Singel, and J. Loscalzo. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J. Clin. Invest. 91: 308-318, 1993.
28. Starkebaum, G., and J. M. Harlan. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77: 1370-1376, 1986.
29. Tsai, J. C., M. A. Perrella, M. Yoshizumi, C. M. Hsieh, E. Haber, R. Schlegel, and M. E. Lee. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc. Natl. Acad. Sci. USA 91: 6369-6373, 1994.
30. Ueland, P. M., S. Heiland, O. J. Broch, and J. S. Schanche. Homocysteine in tissues of the mouse and rat. J. Biol. Chem. 259: 2360-2364, 1984.
31. Ueland, P. M., and H. Refsum. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J. Lab. Clin. Med. 114: 473-501, 1989.
32. Verhoef, P., C. H. Hennekens, M. R. Malinow, F. J. Kok, W. C. Willett, and M. J. Stampfer. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke 25: 1924-1930, 1994.
33. Wall, R. T., J. M. Harlan, L. A. Harker, and G. E. Striker. Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb. Res. 18: 113-121, 1980.
34. Wei, E. P., H. A. Kontos, C. W. Christman, D. S. DeWitt, and J. T. Povlishock. Superoxide generation and reversal of acetylcholine-induced cerebral arteriolar dilation after acute hypertension. Circ. Res. 57: 781-787, 1985.
35. Wei, E. P., R. Kukreja, and H. A. Kontos. Effects in cats of inhibition of nitric oxide synthesis on cerebral vasodilation and endothelium-derived relaxing factor from acetylcholine. Stroke 23: 1623-1628, 1992.